9th Immunotherapy of Cancer conference (ITOC): A meeting report
The Immunotherapy of Cancer conference (ITOC) is an European meeting providing a global platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and the latest findings about immuno-oncology. The 9th ITOC was held in Munich in September 2022. Maj...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2022.2159706 |
| _version_ | 1797673095342850048 |
|---|---|
| author | Iman Dalloul Thaddäus Jan Clemens Strzalkowski Michael von Bergwelt-Baildon Volkmar Nüssler Christoph Zielinski Sebastian Kobold |
| author_facet | Iman Dalloul Thaddäus Jan Clemens Strzalkowski Michael von Bergwelt-Baildon Volkmar Nüssler Christoph Zielinski Sebastian Kobold |
| author_sort | Iman Dalloul |
| collection | DOAJ |
| description | The Immunotherapy of Cancer conference (ITOC) is an European meeting providing a global platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and the latest findings about immuno-oncology. The 9th ITOC was held in Munich in September 2022. Major highlights of the 2022 edition included the key note address and life time achievement to Laurence Zitvogel on her contributions on the understanding of the role of microbiota in cancer development and therapy resistance. Her research has paved the way for therapeutic exploitation of the microbiome. |
| first_indexed | 2024-03-11T21:39:37Z |
| format | Article |
| id | doaj.art-430af30411af443086d9386da3dfdf4c |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:39:37Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-430af30411af443086d9386da3dfdf4c2023-09-26T13:25:47ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-12-0118710.1080/21645515.2022.215970621597069th Immunotherapy of Cancer conference (ITOC): A meeting reportIman Dalloul0Thaddäus Jan Clemens Strzalkowski1Michael von Bergwelt-Baildon2Volkmar Nüssler3Christoph Zielinski4Sebastian Kobold5University Hospital, Ludwig-Maximilians-Universität München, Member of the German Center for Lung Research (DZL)University Hospital, Ludwig-Maximilians-Universität München, Member of the German Center for Lung Research (DZL)German Center for Translational Cancer Research (DKTK)Tumorzentrum MünchenWiener PrivatklinikUniversity Hospital, Ludwig-Maximilians-Universität München, Member of the German Center for Lung Research (DZL)The Immunotherapy of Cancer conference (ITOC) is an European meeting providing a global platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and the latest findings about immuno-oncology. The 9th ITOC was held in Munich in September 2022. Major highlights of the 2022 edition included the key note address and life time achievement to Laurence Zitvogel on her contributions on the understanding of the role of microbiota in cancer development and therapy resistance. Her research has paved the way for therapeutic exploitation of the microbiome.http://dx.doi.org/10.1080/21645515.2022.2159706itocimmunotherapaytumor microenvironementtumor vaccinationcellular therapycombination therapy |
| spellingShingle | Iman Dalloul Thaddäus Jan Clemens Strzalkowski Michael von Bergwelt-Baildon Volkmar Nüssler Christoph Zielinski Sebastian Kobold 9th Immunotherapy of Cancer conference (ITOC): A meeting report Human Vaccines & Immunotherapeutics itoc immunotherapay tumor microenvironement tumor vaccination cellular therapy combination therapy |
| title | 9th Immunotherapy of Cancer conference (ITOC): A meeting report |
| title_full | 9th Immunotherapy of Cancer conference (ITOC): A meeting report |
| title_fullStr | 9th Immunotherapy of Cancer conference (ITOC): A meeting report |
| title_full_unstemmed | 9th Immunotherapy of Cancer conference (ITOC): A meeting report |
| title_short | 9th Immunotherapy of Cancer conference (ITOC): A meeting report |
| title_sort | 9th immunotherapy of cancer conference itoc a meeting report |
| topic | itoc immunotherapay tumor microenvironement tumor vaccination cellular therapy combination therapy |
| url | http://dx.doi.org/10.1080/21645515.2022.2159706 |
| work_keys_str_mv | AT imandalloul 9thimmunotherapyofcancerconferenceitocameetingreport AT thaddausjanclemensstrzalkowski 9thimmunotherapyofcancerconferenceitocameetingreport AT michaelvonbergweltbaildon 9thimmunotherapyofcancerconferenceitocameetingreport AT volkmarnussler 9thimmunotherapyofcancerconferenceitocameetingreport AT christophzielinski 9thimmunotherapyofcancerconferenceitocameetingreport AT sebastiankobold 9thimmunotherapyofcancerconferenceitocameetingreport |